Nanoform Finland Oyj (HEL:NANOFH)

Market Cap	101.61M
Revenue (ttm)	3.66M
Net Income (ttm)	-23.43M
Shares Out	85.53M
EPS (ttm)	-0.28
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	126,519
Average Volume	88,498
Open	1.200
Previous Close	1.188
Day's Range	1.182 - 1.334
52-Week Range	1.042 - 2.785
Beta	0.74
RSI	51.18
Earnings Date	May 20, 2025

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP,...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 181
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: NANOFH

Financial Performance

In 2024, Nanoform Finland Oyj's revenue was 3.66 million, an increase of 42.70% compared to the previous year's 2.57 million. Losses were -23.43 million, 12.9% more than in 2023.